Alrizomadlin
Alrizomadlin (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC50 and Ki values of 3.8 nM and 1 nM, respectively[1]. Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in a p53-dependent manner[2][3].
Product Specifications
CAS Number
1818393-16-6
Product Name Alternative
APG-115; AA-115
UNSPSC
12352005
Target
Apoptosis; E1/E2/E3 Enzyme; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/apg-115.html
Concentration
10mM
Purity
98.57
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1)[C@]([C@@H](C(C=CC=C2Cl)=C2F)[C@@H]3C(NC45CCC(C(O)=O)(CC5)CC4)=O)(C(C1=C6)=CC=C6Cl)C7(CCCCC7)N3CC
Molecular Formula
C34H38Cl2FN3O4
Molecular Weight
642.59
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
(3-Aminopropyl)ethyl-carbamic Acid tert-Butyl Ester
HSV1 (Herpes Simplex Virus Type I) (HSV1/1934), CF594 conjugate, 0.1mg/mL
